TRAVASOL 2.75% IN DEXTROSE 5% IN PLASTIC CONTAINER-美国FDA药品数据库-药物在线

产品信息

产品号	商品名	活性成分	剂型/给药途径	规格/剂量	参比药物(RLD)	生物等效参考标准(RS)	治疗等效代码	该申请号批准日期	该产品号批准日期	市场状态
001	TRAVASOL 2.75% IN DEXTROSE 5% IN PLASTIC CONTAINER	AMINO ACIDS; DEXTROSE	INJECTABLE;INJECTION	2.75%;5GM/100ML	No	No	None	1988/09/23	1988/09/23	Discontinued
002	TRAVASOL 2.75% IN DEXTROSE 10% IN PLASTIC CONTAINER	AMINO ACIDS; DEXTROSE	INJECTABLE;INJECTION	2.75%;10GM/100ML	No	No	None		1988/09/23	Discontinued
003	TRAVASOL 2.75% IN DEXTROSE 15% IN PLASTIC CONTAINER	AMINO ACIDS; DEXTROSE	INJECTABLE;INJECTION	2.75%;15GM/100ML	No	No	None		1988/09/23	Discontinued
004	TRAVASOL 2.75% IN DEXTROSE 20% IN PLASTIC CONTAINER	AMINO ACIDS; DEXTROSE	INJECTABLE;INJECTION	2.75%;20GM/100ML	No	No	None		1988/09/23	Discontinued
005	TRAVASOL 2.75% IN DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS; DEXTROSE	INJECTABLE;INJECTION	2.75%;25GM/100ML	No	No	None		1988/09/23	Discontinued
006	TRAVASOL 4.25% IN DEXTROSE 5% IN PLASTIC CONTAINER	AMINO ACIDS; DEXTROSE	INJECTABLE;INJECTION	4.25%;5GM/100ML	No	No	None		1988/09/23	Discontinued
007	TRAVASOL 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER	AMINO ACIDS; DEXTROSE	INJECTABLE;INJECTION	4.25%;10GM/100ML	No	No	None		1988/09/23	Discontinued
008	TRAVASOL 4.25% IN DEXTROSE 15% IN PLASTIC CONTAINER	AMINO ACIDS; DEXTROSE	INJECTABLE;INJECTION	4.25%;15GM/100ML	No	No	None		1988/09/23	Discontinued
009	TRAVASOL 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER	AMINO ACIDS; DEXTROSE	INJECTABLE;INJECTION	4.25%;20GM/100ML	No	No	None		1988/09/23	Discontinued
010	TRAVASOL 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER	AMINO ACIDS; DEXTROSE	INJECTABLE;INJECTION	4.25%;25GM/100ML	No	No	None		1988/09/23	Discontinued

批准日期，申请提交历史，通知信，药品说明书，审评文件等信息

提交状态日期	提交号	审批结论	申请内容分类	审评优先级；罕用药状态	通知信、审评文件、说明书、包装标签
2001/08/14	SUPPL-21（补充）	Approval	Manufacturing (CMC)	STANDARD
2000/04/12	SUPPL-18（补充）	Approval	Efficacy	STANDARD	Letter
2000/03/24	SUPPL-20（补充）	Approval	Manufacturing (CMC)	STANDARD
1999/11/24	SUPPL-19（补充）	Approval	Manufacturing (CMC)	STANDARD
1999/03/31	SUPPL-17（补充）	Approval	Manufacturing (CMC)	STANDARD
1997/11/18	SUPPL-16（补充）	Approval	Labeling	STANDARD
1997/04/29	SUPPL-15（补充）	Approval	Manufacturing (CMC)	STANDARD
1994/09/30	SUPPL-12（补充）	Approval	Manufacturing (CMC)	STANDARD
1994/05/19	SUPPL-13（补充）	Approval	Manufacturing (CMC)	STANDARD
1994/02/18	SUPPL-14（补充）	Approval	Manufacturing (CMC)	STANDARD
1993/05/05	SUPPL-5（补充）	Approval	Manufacturing (CMC)	STANDARD
1992/09/14	SUPPL-6（补充）	Approval	Manufacturing (CMC)	STANDARD
1992/08/24	SUPPL-7（补充）	Approval	Manufacturing (CMC)	STANDARD
1992/02/27	SUPPL-9（补充）	Approval	Manufacturing (CMC)	STANDARD
1992/02/27	SUPPL-8（补充）	Approval	Labeling
1991/12/30	SUPPL-11（补充）	Approval	Manufacturing (CMC)	STANDARD
1991/03/26	SUPPL-4（补充）	Approval	Manufacturing (CMC)	STANDARD
1991/02/15	SUPPL-2（补充）	Approval	Manufacturing (CMC)	STANDARD
1990/05/04	SUPPL-3（补充）	Approval	Manufacturing (CMC)	STANDARD
1989/07/26	SUPPL-1（补充）	Approval	Manufacturing (CMC)	STANDARD
1988/09/23	ORIG-1（原始申请）	Approval	Type 5 - New Formulation or New Manufacturer	STANDARD

与本品相关的专利信息（来自FDA橙皮书Orange Book）

关联产品号	专利号	专利过期日	是否物质专利	是否产品专利	专利用途代码	撤销请求	提交日期	专利下载	备注
无

与本品相关的市场独占权保护信息

关联产品号	独占权代码	失效日期	备注
无

与本品治疗等效的药品

本品无治疗等效药品